
So excited to share our data on #LynchSyndrome and risk of new neoplasia after immunotherapy Thank you to our terrific colleagues @EmilyHarrold6 @MikeFooteMD @BenjcRousseau @ldiaz1971 and many others @MSK_DeptOfMed
⚡ Our October issue is live! Featuring checkpoint inhibitor therapy for #LynchSyndrome, senolytic treatment for #Alzheimersdisease and studies on #diabetes, #PTSD, #autism and #NASH, as well as an editorial on weight-loss drugs, News, Opinion and more... nature.com/nm/volumes/29/iss…



























